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S U M M A R Y
Objectives: The habitual chewing of betel quid (areca nut, betel leaf, tobacco) is estimated to occur among
600 million persons in Asia and the Asia-Paciﬁc Region. Emerging data from rural Asia indicate that the
betel quid is part of traditional medicine practices that promote its use for a wide range of ailments,
including infectious disease. In the present study, we examined the association between betel quid,
traditional medicine, and infectious disease outcomes.
Methods: For the purpose of a nationwide, interviewer-administered, cross-sectional survey of tobacco
use (including betel quid), we conducted a stratiﬁed three-stage cluster sampling of 13 988 adults aged
18 years and older from all provinces of Cambodia.
Results: We found an association between the intensity of betel quid use and HIV/AIDS (odds ratio (OR)
2.06, 95% CI 1.09–3.89), dengue fever (OR 2.40, 95% CI 1.55–2.72), tuberculosis (OR 1.50, 95% CI 0.96–
2.36), and typhoid (OR 1.48, 95% CI 0.95–2.30). These associations were even stronger in women – the
primary users of betel quid in Cambodia. Multivariable analyses that controlled for age, gender, income,
education, urban versus rural dwelling, receiving care from traditional medicine practitioners, and
cigarette smoking did not alter the betel quid–infectious disease association.
Conclusions: Our ﬁndings raise the possibility of a role of betel quid use in the transmission of infectious
disease through pathways such as immunosuppression, oral route of entry for a pathogen (i.e., through
injury to the oral mucosa), and contamination (i.e., fecal–oral) of the betel quid ingredients.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Betel quid use involves the chewing of areca nut (Areca catechu
L. (Arecaceae)), betel leaf (Piper betle L. (Piperaceae)), slaked lime
(calcium hydroxide), and tobacco, and is practiced by 600 million
persons in Asia, South Asia, and Southeast Asia,1–3 and also among
migrants from those regions living in Western nations.4 Large-
scale prospective cohort studies in India and Taiwan have shown
that betel quid use in women and men is associated with a 20–30%
increase in the all-cause mortality rate.5,6 Some of the chronic
diseases underlying this trend include (1) a well-known associa-
tion with oral cancer, oral leukoplakia, and submucous ﬁbrosis,
which have primarily been attributed to the formation of
carcinogenic N-nitroso compounds produced by the quid,7 and
(2) a growing body of evidence of a link with cardiovascular disease
and diabetes.8–10 Although a relationship between betel quid and
periodontal infections has been reported,11 there is a paucity of
data investigating a link between betel quid and infectious,
communicable disease.* Corresponding author. Tel.: +1 909 558 4590; fax: +1 909 558 0326.
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doi:10.1016/j.ijid.2011.12.006Qualitative and quantitative data are emerging from several
nations indicating that the use of betel quid may be an integral part
of cultural, familial, and traditional medicine practices.3,4,12,13
Speciﬁcally, the betel quid ingredients are known throughout Asia
and South Asia for their medicinal effects as a stimulant, a digestive
aid (speciﬁcally for the relief of morning sickness during
pregnancy),12 an antiseptic, a de-worming agent, a pain reliever,
and for the treatment of infectious disease.13 During a large-scale
prevalence study of tobacco use in Cambodia (N = 13 988)12,14 in
2005–2006, we found that (1) about half the older women (>48
years) are habitual betel quid users, (2) one out of ﬁve women
started the habit during pregnancy in response to morning
sickness,15 and (3) by occupation the highest prevalence of
chewing tobacco was among midwives (67.9%) and traditional
healers (47.1%). These data raise the possibility that traditional
medicine practices are inﬂuencing the initiation and use of the
betel quid in Cambodia.
In the current analyses of this national sample of 13 988 adults in
Cambodia,12 our aims were (1) to examine the association between
habitual betel quid use and speciﬁc infectious diseases (HIV/AIDS,
tuberculosis, dengue fever, typhoid), and (2) to examine the
association between betel quid use and the use of traditional
medicine services (i.e., traditional healer, traditional birth attendant,ses. Published by Elsevier Ltd. All rights reserved.
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multivariable analysis of infectious diseases.
2. Methods
2.1. Study population
The study population has been described extensively else-
where.12,14,16 Brieﬂy, for the survey, we assembled a nationwide,
representative sample of 13 988 adults aged 18 years and older.
We worked with the National Institute of Statistics (Ministry of
Planning, Cambodia) to conduct a stratiﬁed three-stage cluster
sampling using the Cambodia General Population Census as a
sampling frame.17 Speciﬁcally, we stratiﬁed the country into 17
sampling domains consisting of 12 individual provinces and ﬁve
groups of similar provinces. Within each domain, we then
randomly selected villages (we use the term ‘village’ to represent
a rural village or urban area of comparable size) in multiple stages
(by district and census block areas (representing 110 households)).
We found that less than 3% declined to complete the ﬁnal
household survey. The ﬁnal sample consisted of 13 988 adults.
Written informed consent was obtained from each subject and
the protocols for the national survey and validation sub-studies
were approved by the Institutional Review Board of Loma Linda
University and the National Ethics Committee on Health (Ministry
of Health) in Cambodia.
2.2. Questionnaire
Survey items were designed during focus groups,18 survey
research training of Ministry of Health (Cambodia) personnel,16
and consultation with local non-governmental organizations (i.e.,
the Adventist Development and Relief Agency; ADRA) that had
conducted tobacco surveys. The ﬁnal survey was conducted in the
local language (Khmer) after being translated using methods
described by Flaherty et al.19
The 2005–2006 national prevalence survey was interviewer-
administered (census workers from the National Institute of
Statistics, Ministry of Planning, Cambodia) and included items on
demographics, tobacco use (commercial cigarettes, hand-rolled
cigarettes, chewing tobacco and betel quid, tobacco pipe), age at
initiation of tobacco, reasons for starting to smoke, knowledge and
attitudes about tobacco, smoking cessation, anthropometrics, diet,
current health, women’s health, and media exposure. In addition to
dichotomous measures of current betel quid use, the survey data
allowed for an index of betel quid use (times per month) that was
computed by: number of days per month chewing betel quid 
number of times per day. In this context, a ‘time per day’ is deﬁned
as a session where the betel leaf, areca nut, slaked lime, and
tobacco are combined into a packet and chewed and/or maintained
in the gingival pocket. This index was further modiﬁed by a
pictogram-derived weighting factor that allowed subjects to
estimate (using pictures depicting weighed amounts of tobacco)
the amount of tobacco that was added to the betel quid. This
procedure has been described and validated elsewhere.12,20,21
Access to health care was assessed using an item that had been
developed by the National Institute of Statistics, Ministry of Planning,
Cambodia for ‘Demographic and Health’ and socioeconomic surveys
during 2000–2007.17,22 These items classiﬁed health care options for
the national sample into the following three categories: (1) public
medical sector (national hospital, provincial referral hospital, district
hospital, health center, health post, outreach), (2) private medical
sector (private hospital, private clinic, home/ofﬁce of trained health
worker/nurse), and outside the medical sector (private pharmacy,
store selling drugs, traditional healer (‘Kru Khmer’, ‘Magician’),
traditional birth attendant, faith-based healer). These data were usedto identify subjects who used traditional medicine practitioners
(traditional healers, traditional birth attendants, other faith-based
healers) when they were seeking health care.
Items on self-report of infectious disease and infectious disease
symptoms were adapted from the ‘Demographic Health Surveys’
administered in 2000 and 2007.22 For each infectious disease
(tuberculosis, dengue fever, HIV/AIDS, typhoid, malaria) subjects
were asked whether a doctor or other health worker had ever
diagnosed them with the disease. Symptoms were obtained using
an item that asked about illness and/or health problems during the
past 4 weeks.
2.3. Statistical analysis
Data analysis for this study needed to account for the stratiﬁed,
multi-stage cluster sampling protocol described above. The 95%
conﬁdence intervals (95% CI) for prevalence, means, and odds
ratios (OR) for tobacco use and health variables were calculated
using a Taylor series linearized approach to compute between-
cluster variance estimators that accounted for the intra-cluster
correlation among subjects within the same village. Point
estimates for prevalence, means, and OR were further adjusted
by sample weights to account for different sampling fractions
within each of the 17 domains described above. OR were derived
from logistic regression models with dependent variables such as
the use of traditional medicine and speciﬁc disease outcomes. The
exposure variables tested in the model were for betel quid use
(current use (yes/no), frequency of use of the quid, by subject’s
estimate of weight of tobacco in the quid using a picture card).
Confounders were included that changed the exposure point
estimate to a meaningful extent. These statistical analyses were
performed using SUDAAN software release 9.0 (RTI International,
Research Triangle Park, NC, USA).
3. Results
The demographics of the study population (N = 13 988) have
been published elsewhere.12,14 Brieﬂy, the survey data indicated
that the sample was more than 95% Khmer ethnicity, Buddhist, and
had completed 12 years of education or less. By income and
occupation, we found that 87% earned less than 2 US dollars (USD)
per day, with farming and labor being the most common
occupations (64%). We compared the demographics and health
status of betel quid users and non-users (Table 1). We found that
betel quid users tended to be older, female, rural dwelling, with
lower income, less education, and higher rates of tuberculosis. The
prevalence of using traditional medicine was slightly higher in
users (14%) than non-users (11%). These differences all attained
statistical signiﬁcance (p < 0.05) in contingency table analysis
(Chi-square for independence), with the exception of the higher
rate of tuberculosis in betel quid users, which was marginal
(p = 0.08).
3.1. Use of traditional medicine and betel quid use
In a logistic regression model with use of traditional medicine
(deﬁned as traditional healers (‘Kru Khmer’), traditional birth
attendants, or other faith-based healers) as the outcome variable
and age and betel quid use as covariates, we found that betel quid
users were 41% more likely (OR 1.41, 95% CI 1.04–192) to use
traditional medicine than non-users and that this effect persisted
even after control for income, education, and rural residence. Since
the prevalence of betel quid use in men is quite low (1.0%),12 we
conducted an analysis of all subjects and of women separately.
Among women, who are the major users of betel quid in
Cambodia,12 we found betel quid users to be 51% (OR 1.51, 95%
Table 1
Prevalence of selected demographic variables in a nationwide sample of 13 988
adults (aged 18 years and older) from Cambodia
Variables All (%) Betel quid
user (%)
Betel quid
non-user (%)
Age (years)a
18–25 26.7 1.5 29.5
26–36 23.2 8.6 24.8
37–48 25.5 24.9 25.6
>48 24.6 65.0 20.2
Gendera
Male 43.6 4.4 48.0
Female 56.4 95.6 52.0
Residencea
Rural 83.0 93.8 81.8
Urban 17.0 6.2 18.2
Ethnicitya
Khmer 95.1 94.5 95.2
Cham 3.1 5.1 2.9
Local tribeb 0.6 0.3 0.7
Otherc 1.2 0.1 1.3
Religiona
Buddhist 95.6 94.6 95.8
Muslim 3.1 4.2 2.9
Christian 0.4 0.2 0.4
Otherd 0.9 1.0 0.8
Educationa
0–6 y 74.3 97.8 71.6
7–12 y 23.3 2.2 25.6
13–15 y 1.4 0 1.6
>15 y 1.1 0 1.2
Income per day (USD)a
<1 74.1 90.3 72.3
1–2 12.6 5.9 13.3
>2–3 5.7 2.2 6.1
>3 7.6 1.6 8.3
Seek care from traditional
medicine practitionera
Yes 11.4 14.7 11.1
No 88.6 85.3 88.9
Disease history
Tuberculosis 2.9 4.0 2.8
Typhoid fever 4.9 4.1 4.9
Dengue fever 0.4 0.5 0.4
HIV/AIDS 0.5 0.8 0.5
Malaria 2.5 1.8 2.6
USD, US dollars.
a p < 0.05 for a Chi-square test evaluating the null hypothesis of independence
between the demographic variable and betel quid use.
b Indigenous ‘hill tribes’ found throughout Southeast Asia.
c Chinese, Vietnamese, Laos, Thai, Other.
d Local or tribal religions (i.e., Animist).
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controlling for income, education, and rural status this effect
was attenuated, albeit statistically signiﬁcant. Based on these data,
we decided to control for traditional medicine when investigatingTable 2
Association between intensity of betel quid use (per 10 g tobacco added to each quid) and
2006)
Disease All 
Age-adjusted OR (95% CI) Multivariablea OR (95%
Tuberculosis 1.50 (0.96–2.36) 1.39 (0.87–2.31) 
p = 0.08 p = 0.21 
Typhoid 1.48 (0.95–2.30) 1.53 (0.99–2.34) 
p = 0.08 p = 0.06 
HIV/AIDS 2.06 (1.09–3.89) 2.04 (1.10–3.70) 
p = 0.03 p = 0.02 
Dengue fever 2.40 (1.55–2.72) 2.58 (1.70–3.93) 
p = 0.0001 p < 0.0001 
Malaria 0.86 (0.38–1.92) 1.49 (1.03–2.18) 
p = 0.71 p = 0.04 
OR, odds ratio; CI, conﬁdence interval.
a Adjusted for age and the following additional covariables: gender, income, educatithe relationship between betel quid use and infectious disease
(Table 2).
3.2. Betel quid use and infectious disease outcomes
In logistic regression models with speciﬁc disease outcomes
(tuberculosis, typhoid fever, dengue fever, HIV/AIDS) as the
dependent variable, we found that betel quid users were 2.6
times (OR 2.6, 95% CI 0.91–7.45) more likely to report a diagnosis of
HIV/AIDS. Among women, a strong association was found for betel
quid use and dengue fever (OR 3.01, 95% CI 1.01– 9.73). Among
men, a strong association was found for betel quid use and
tuberculosis (OR 4.43, 95% CI 1.66–11.86), but this was based on a
small case series due to the low prevalence of use in men (eight
tuberculosis cases among 63 betel quid users;168 tuberculosis
cases among 6139 non-users).
In further analyses (Table 2) that explored the intensity of betel
quid use (odds of disease per 10 g of tobacco added to each quid),
we found an association with dengue fever (OR 2.40, 95% CI 1.55–
2.72), HIV/AIDS (OR 2.06, 95% CI 1.09–3.89), typhoid (OR 1.48, 95%
CI 0.95–2.30), and tuberculosis (OR 1.50, 95% CI 0.96–2.36). These
ﬁndings persisted in the multivariable analysis where we
controlled for age, poverty-related factors (education, income,
urban/rural residence, seek care from traditional medicine), and
current cigarette smoking. Among women (Table 2), the associa-
tion with these diseases was even stronger and also included a
betel quid–malaria association. The prevalence of use among men
was too low for stratum-speciﬁc analysis.
4. Discussion
Our ﬁndings from a national sample of adults in Cambodia
indicate an association between the intensity of habitual, daily
betel quid use and HIV/AIDS, dengue fever, typhoid, and
tuberculosis. These ﬁndings (Table 2) were even stronger among
Cambodian women – a group for whom betel quid is the primary
form of tobacco use. We have considered causal, intermediate, and
reverse causal pathways to explain these ﬁndings (Figure 1).
4.1. Is habitual betel quid use a pre-disposing factor for opportunistic
infectious disease?
Our ﬁndings link habitual betel quid use to disease caused by a
range of viral and bacterial pathogens that are typically transmit-
ted through mosquitoes (dengue fever, malaria), food and drink
(typhoid), and person-to-person contact (HIV/AIDS, tuberculosis).
We note that even though habitual betel quid use may not
represent direct exposure to a pathogen, betel quid use could
potentially increase the risk of infection through pathways such as disease outcomes among 13 988 adults in a national sample from Cambodia (2005–
Women only
 CI) Age-adjusted OR (95% CI) Multivariablea OR (95% CI)
1.57 (0.97–2.55) 1.42 (0.85–2.37)
p = 0.07 p = 0.18
1.58 (1.03–2.44) 1.56 (1.01–2.41)
p = 0.04 p = 0.05
2.03 (1.06–3.89) 2.06 (1.11–3.82)
p = 0.03 p = 0.02
3.12 (2.17–4.19) 3.44 (2.25–5.25)
p < 0.0001 p < 0.0001
1.60 (1.16–2.22) 1.58 (1.13–2.20)
p = 0.004 p = 0.008
on, urban/rural, use of traditional medicine healer, current smoking.
Figure 1. Multi-state model linking betel quid use to infectious disease through causal, intermediate, and reverse causal pathways.
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pression, or due to transmission by the person-to-person contact
that occurs in the preparation and chewing of betel quid (i.e.,
typically a group behavior among women of the Western Paciﬁc
Region).
4.2. Route of entry for pathogens and immunosuppression
Betel quid use could potentially increase the risk of
developing infectious disease by providing an oral route of
entry for pathogens through the constant injury to the oral
mucosa. Speciﬁcally, Ling et al.11 found that betel quid chewers
tended to exhibit signiﬁcantly more bleeding on probing,
gingival inﬂammation, and attachment loss –indicators of
periodontal disease in this sample that were also linked to
infection (i.e., Actinobacillus actinomycetemcomitans, Porphyro-
monas gingivalis). Long-term betel quid use also provides an oral
route of entry since it is associated with (1) a characteristic
‘betel chewer’s perle`che’ that consists of ﬁssures at angles in the
mouth due to constant exposure,23 (2) a characteristic oral
leukoplakia in the gingival area, and (3) a submucosal ﬁbrosis
thought to be caused by the calcium hydroxide paste added to
the quid. Among Cambodian female betel quid users, Reichart
et al. found a very high prevalence of oral lesions (betel chewer’s
mucosa (85.4%), oral leukoplakia (8.3%), leukoedema (37.5%),
and oral lichen planus (4.2%)).24
Additionally, several studies have demonstrated that the
submucosal ﬁbrosis, oral leukoplakia, and oral erythroplakia
that are commonly associated with betel quid, can impair a wide
range of immune function parameters (Figure 1), which include
but are not limited to: CD3 cells (T lymphocytes), CD4 cells
(helper/inducer T lymphocytes), B lymphocytes, macrophages,25
natural killer cells,26 total leukocyte and lymphocyte counts,27
immunoglobulin (Ig) G, IgM, and IgA,28,29 circulating immune
complex,30 auto-antibodies such as gastric parietal cell antibody
(GPCA), thyroid microsomal antibody, anti-nuclear antibody
(ANA), anti-reticulin antibody, and anti-smooth muscle anti-
body (SMA).31 Thus, under such a level of constant immuno-
suppression, it is biologically plausible that users experience an
increased risk of opportunistic infection transmitted throughother means (mosquito bite, food and drink, and risky sexual
practices).
It is also noteworthy that the nicotine component from tobacco
added to the quid may also induce immune suppression by
affecting both humoral and cell-mediated immune responses,32–35
and additionally producing an altered immune response that is
characterized by a decline in inﬂammation, a reduction in antibody
response, and a decrease in T-cell receptor-mediated signaling.36
The arecoline component of the areca nut has also been shown in
rodent models to have a possible immunomodulatory effect.37–39
4.3. Behaviors associated with betel quid preparation and chewing
Certain patterns of behavior associated with betel quid chewing
in rural areas of the Western Paciﬁc Region can potentially
contribute to the transmission of infectious disease. In 200612 and
201140 national surveys of tobacco use, we reported that of the two
million tobacco users in Cambodia, about 500 000 are women who
chew a betel quid that consists of the areca nut, slaked lime, betel
leaf, and loose tobacco. In contrast to South Asia, in rural areas of
Cambodia the betel quid is not a pre-packaged commercial
product, but rather is prepared by hand in such a way that the
betel leaf is wrapped around the areca nut, slaked lime, and
tobacco.2,5 This type of handling and preparation by users can
promote fecal–oral transmission of typhoid bacteria when
unwashed hands are involved in the preparation of the quid
and/or insertion of the ‘quid’ into the gingival pocket. Direct
contamination of betel quid ingredients (i.e., due to unsanitary
conditions in storage) before preparation is also noteworthy.
Lastly, it is noteworthy that many of the alkaloids (i.e.,
arecoline) found in the areca nut component of the betel quid
are primarily parasympathetic in action and acutely stimulate
glandular secretion (i.e., salivary, lacrimal) during a betel quid
chewing session.41 Thus, betel quid chewing produces large
volumes of saliva and frequent spitting of both the excess saliva
and quid. Moreover, the communal environment of groups of
chewers sitting in proximity to one another and spitting the excess
saliva–quid mixture can increase person-to-person transmission
of tuberculosis and other pathogens through contact with saliva
droplets.
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causation?
We considered the possibility of ‘reverse causation’, where a
betel quid–infectious disease relationship may be partly attribut-
able to betel quid being used for medicinal purposes. In
multivariable analyses (Table 2) where we controlled for the use
of traditional medicine for the treatment of illness, the associations
between betel quid and infectious disease indicated no important
change in effect. Also, another argument against ‘reverse causation’
is that the associations with infectious disease depicted in Table 2
were for habitual, daily betel quid use and not for use during
illness.
Despite this, we note that our survey does not measure
behavioral patterns whereby after the onset of illness, betel quid
use is increased among current users or becomes a reason for the
initiation of use. The co-existence of causal, intermediate, and/or
reverse causal pathways depicted in Figure 1 raises the possibility
of a ‘vicious cycle’, where increased betel quid use post-infection
(i.e., to alleviate symptoms) further suppresses immune function.
In recent key informant interviews in Cambodia that were
published in 2008 in the national newspaper, a betel nut shop
owner indicated that ‘‘I do not know if [betel quid] affects our
health, but betel leaf and areca are important in curing typhoid’’.
The 63-year-old woman further indicated that betel quid
ingredients ‘‘are Cambodian traditional medicine’’.42 Such beliefs
were also evident in our ﬁnding from the national survey data of
Cambodia showing that one out of ﬁve women indicated that they
started chewing betel quid during pregnancy as a relief for the
symptoms of morning sickness.15 Some of this practice may relate
to long-held beliefs among traditional medicine practitioners and
herbalists that the areca nut-derived alkaloids (i.e., arecoline) are a
remedy for relaxing the stomach and ileum.43
Do traditional medicine beliefs in Asia include the use of betel
quid as prevention/treatment of infectious disease? In Asia and the
Asia Paciﬁc Region, traditional medicine practitioners have long
touted the ‘betel leaf’ (leaf of the areca nut palm tree, Areca catechu)
as a treatment for typhoid, cholera, tuberculosis, conjunctivitis, ear
infection, boils, abscesses, and ringworm.44,45 The rationale for this
treatment is a belief that essential oils in the betel leaf exhibit
antibacterial, anti-protozoan, and antifungal properties.13 Tradi-
tional medicine in India also point to the vitamin and mineral
content of the betel quid in the common claim that six betel leaves
in combination with slaked lime (calcium hydroxide) have a
vitamin and mineral content equivalent to 300 ml of cow milk.13
4.5. Implications for global epidemiology of betel quid use
Our ﬁndings from Cambodia indicate a strong association
between betel quid use and infectious disease that is occurring
among users who are predominantly non-smoking women – a
trend that is found throughout the Western Paciﬁc Region.2 In
Southeast Asia (Cambodia,12 Myanmar,46 Thailand,47 and Viet-
nam48), betel quid is primarily used by middle-aged and older
women (7–46% prevalence) and has been described as being a ‘rite
of passage into womanhood’.4 Betel quid use in the Asia-Paciﬁc
Region (Palau, Papua New Guinea, and Malaysia) exceeds 50%
among rural women.7,49–51 The potential co-aggregation of betel
quid exposure and infectious disease in women of reproductive age
in this region is an especially alarming scenario when considering
the lethal consequences of transplacental transmission of the
pathogen (i.e., HIV) and betel quid metabolites. Maternal betel quid
use has been associated with a higher rate of stillbirth in cohort
studies in India.52
When considering the infectious disease burden associated
with betel quid use it is also important to note that in other parts ofAsia (India, Pakistan, and Taiwan) the habit occurs in all adults,
including males, and may occur together with cigarette smoking.2
Among the few men who did use betel quid in Cambodia we found
a more than four-fold increase in the rate of tuberculosis. Recent
national (India)53 and global54 estimates have strongly linked
smoked tobacco to a signiﬁcant burden of tuberculosis. Our
ﬁndings raise the possibility that smokeless tobacco also contrib-
utes to this burden of tuberculosis.
4.6. Limitations
There are several limitations of this study that should be noted.
The cross-sectional design does not allow us to entirely separate
causal, intermediate, and non-causal scenarios for betel quid and
infectious disease. Differentiating between these scenarios would
require studies of betel quid use during disease and illness. Also
useful would be the ﬁndings from prospective investigations of
betel quid use and disease outcomes in the region. Measurement
error in the survey measures of both the self-reported disease and
the betel quid items should be mentioned. Our validation study of
the tobacco items, however, showed excellent results.
5. Conclusions
Our ﬁndings indicate a strong association between betel quid
use and infectious disease and underscore the need for studies in
rural Southeast Asia that are designed to investigate bio-behavioral
frameworks that include (1) oral health outcomes from betel quid
use contributing to immune suppression that increases the risk of
infectious disease, (2) oral health outcomes from betel quid use
providing a route of entry for pathogens, (3) bacterial contamina-
tion (fecal–oral) of betel quid ingredients leading to transmission
of infectious disease, (4) person-to-person transmission through
contact with salivary droplets of infected users, and (5) changing
and initiating patterns of betel quid use as part of traditional
medicine remedies.
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